(Q41697237)

7 October 2017

title

Development of a rectal nicotine delivery system for the treatment of ulcerative colitis (English)

1 reference

7 October 2017

A K Dash

1

1 reference

7 October 2017

Z Gong

2

1 reference

7 October 2017

D W Miller

3

1 reference

7 October 2017

H Huai-Yan

4

1 reference

7 October 2017

J Laforet

5

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

International Journal of Pharmaceutics

7 October 2017

published in

1 reference

7 October 2017

volume

190

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

21-34

1 reference

The application of cell culture systems in drug discovery and development

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

New salicylate therapies for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

5-Aminosalicylic acid suppositories in the management of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Determination of the physical state of drug in microcapsule and microsphere formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Solid-state properties of tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Pharmaceutical Applications of Polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Non-smoking: a feature of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Pathology of inflammatory bowel disease in colorectal mucosal biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Possible mode of action of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Transdermal nicotine for active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Nicotine treatment in ulcerative colitis. Current status

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Transdermal nicotine as maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

Nitric oxide donors enhance rectal absorption of macromolecules in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900221-5

7 January 2021

10.1016/S0378-5173(99)00221-5

Identifiers

DOI

1 reference

7 October 2017

1 reference